Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GoHealth (GOCO) Common Equity (2019 - 2025)

GoHealth's Common Equity history spans 7 years, with the latest figure at -$6.9 million for Q3 2025.

  • For Q3 2025, Common Equity fell 102.0% year-over-year to -$6.9 million; the TTM value through Sep 2025 reached -$6.9 million, down 102.0%, while the annual FY2024 figure was $405.4 million, 0.05% changed from the prior year.
  • Common Equity for Q3 2025 was -$6.9 million at GoHealth, down from $279.1 million in the prior quarter.
  • Across five years, Common Equity topped out at $1.4 billion in Q1 2021 and bottomed at -$6.9 million in Q3 2025.
  • The 5-year median for Common Equity is $460.8 million (2023), against an average of $618.4 million.
  • The largest annual shift saw Common Equity surged 30.32% in 2021 before it plummeted 102.0% in 2025.
  • A 5-year view of Common Equity shows it stood at $892.5 million in 2021, then tumbled by 39.23% to $542.4 million in 2022, then dropped by 25.21% to $405.7 million in 2023, then decreased by 0.05% to $405.4 million in 2024, then tumbled by 101.7% to -$6.9 million in 2025.
  • Per Business Quant, the three most recent readings for GOCO's Common Equity are -$6.9 million (Q3 2025), $279.1 million (Q2 2025), and $397.1 million (Q1 2025).